News

Applied Cells Inc. and GenScript enter strategic collaboration to deliver combined solutions for cell therapy development

0
Science Instruments in laboratory room. Science Research Concept.

November 18th, 2022. Today, Applied Cells Inc. and GenScript USA Incorporated announced their strategic collaboration to deliver combined cell isolation solutions for cell therapy drug development worldwide. Under this collaboration, GenScript will develop and supply its proprietary research and cGMP grade CytoSinct™ reagents for use in developing CAR-T and other Cell Therapy products on the Applied Cells MARS® Platform.

Mexico: Deadly meningitis outbreak caused by anesthetics

Previous article

‘Bones and All’ review: The next great queer horror movie has arrived with a cannibal romance

Next article

You may also like

Comments

Leave a reply

Your email address will not be published. Required fields are marked *

More in News